OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-03-31-accounts

Contents Page
Foreword
from the Chair		 and Chief Executive
Report of the Trustees
Independent
Auditor's
Report		 15
Consolidated
Statement		 of Financial Activities 19
Balance Sheets 20
Statements
of Cash Flows		 21
Notes to the Financial Statements 22

Charity Number: Charity Number: 509294
Company Number: 01451533
Registered Office: 185Tadcaster Road, York, YO241GL

Our advisors
Auditor Azets Audit Services Ltd Triune Court, Monks Cross Drive,
York, YO32 9GZ
Bankers National Westminster 1 Market Street, York, YO1 8SR
Bank
Solicitors Hague 8, Dixon Bank House,
1 The Square,		 Stamford Bridge,
York, YO41 1AG
Lupton Fawcett Stamford
House, Piccadilly,		 York, YO1 9PP
Investment Sarasin 8, Partners LLP Juxon House, 100St Paul's Churchyard,
Managers London,
EC4M 8BU
Ruffer LLP 80Victoria Street, London, SW1E5JL
CCLA Senator House, 85Queen Victoria Street,
London,
EC4V 4ET

Trustees and officers serving during the year and since the during the year and since the year end were as fol
Trustees and directors: David Dickson (Chair)
Sandra Falcus
Prof Kate Flemming
Khushbu
Goulden
Juliette Healey
Prof Mike Holmes
Eamonn
Keogh
Jacqueline
Myers
Dr Lavinia
Norton
Tony Taylor
Melanic Kay (appointed
October 2022)
Kate O' Connell (appointed
November		 2022)
Lorna Allan (appointed June 2023)
Dr Dan Cottingham (resigned June 2022)
Company Secretary: Company Secretary: David Jones
Senior Management Team: Emma Johnson (Chief Executive)
Ingrid Jenner (Director of People)
David Jones (Director of Finance 8,Corporate
Services; appointed September 2022)
Dr Bill Hulme (Medical Director)
Dawn Clements (Director of Income Generation;
resigned July 2023)
Jenny Brandom (Director of Clinical Services; resigned
February 2023)
Anne-Marie
Roberts		 (Director of Clinical Services;
appointed March 2023)
Key management personnel: St.Leonard's
Hospice Enterprises
Limited
Directors: Juliette Healey (Chair)
David Dickson
Mark Shepherd (resigned October 2022)
Tony Taylor (appointed October 2022)
Company Secretary: David Jones

Unrestricted Restricted Total Funds Total
Funds
Funds Funds 2023 2022
Notes Ek Ek Rk Ek
Income from:
Donations and legacies 2,668 217 2,885 5,153
Income from charitable
activities:
Grants and contract income 1,769 383 2,152 2,475
Income from other trading activities:
Shops 2,477 2,477 2,128
Lottery 398 398 387
Fundraising
and other activities		 293 293 394
Investment
Income		 391 391 407
Total income 7,996 600 8,596 10,944
Expenditure
on:
Costs ofraising funds:
Donations and legacies 781 781 592
Shops 1,914 1,914 1,696
Lottery 196 196 192
Fundraising
and other activities		 158 158 151
Investment
Management		 Costs 80 80 81
Expenditure
on charitable		 activities:
In-patient
Care		 3,962 193 4,155 3,771
HospiceHome 530 681 1,211 1,134
Bereavement
and Family Support		 195 195 252
Total expenditure 7,816 874 8,690 7,869
Net income/
(expenditure)
recognised
gains/ (losses)		 before other 180 (274) (94) 3,075
Realised and unrealised
gains/
investments		 (losses) on (551) (551) 472
Net income/
(expenditure)
funds		 and net movement in (371) (274) (645) 3,547
Total funds brought
forward		 24,010 1,118 25,128 21,581
Total funds carried forward 23 23,639 844 24,483 25,128

alance Sh eets as a t 3 1 March 2023
Charity Group
Notes 2023 2022 2023 2022
Rk Rk
Fixed assets
Tangible assets 17 4,484 4,624 4,484 4,624
Investments 18 17,008 14,909 17,008 14,909
Investment properties 18 105 105 105 105
Total fixed assets 21,597 19,638 21,597 19,638
Current assets
Stock 19 16 16 17
Debtors 20 2,576 3,339 2,543 3,286
Cash at bank and in hand 754 2,570 803 2,621
Total current assets 3,346 5,909 3,362 5,924
Liabilities
Creditors
falling due
year		 within one (475) (432) (476) (434)
Net current assets 2,871 5,477 2,886 5,490
Net assets 23 24,468 25,115 24,483 25,128
The funds ofthe charity
Unrestricted Funds:
Unrestricted general funds 10,140 10,373 10,133 10,369
Unrestricted designated funds 13,484 13,624 13,484 13,624
Non-charitable
trading		 funds 22 17
23,624 23,997 23,639 24,010
Restricted income funds 10 844 1,118 844 1,118
Total charity funds 23 24,468 25,115 24,483 25,128

onsolidated
Statement
ofCash Flows fo		 r the year ending
31		 March 2023
2023 2022
Notes Rk Rk
Net cash provided
by operating
activities		 28 634 1,557
Cash flows from investing
activities:
Dividends,
interest and rent from investments		 315 331
Purchase
of property,
plant and equipment		 (56) (46)
Proceeds from the sale of property,
plant and
equipment		 17
Payments
to acquire investments		 (2,728) (501)
Proceeds from the disposal of investments 500
Net cash (used in)/ provided
by financing		 activities (2,452) 284
Change
in cash and cash equivalents
in the year		 (1,818) 1,841
Cash and cash equivalents
at the start of the year		 2,621 780
Total cash and cash equivalents
at the end
year		 ofthe 803 2,621
Analysis
ofcash and cash equivalents
Cash at bank and in hand 803 2,621
803 2,621

e summary financial
per		 formance
of the		 charity alone is:
2023 2022
Rk Rk
Income 8,532 10,880
Gift Aid from subsidiary 24 30
company
8,556 10,910
Expenditure (8,652) (7,835)
Net income/expenditure (96) 3,075
Investment gains (551) 472
Total funds brought
forward		 25,115 21,568
Total funds carried forward 24,468 25,115
Represented by:
Unrestricted income funds 10,140 10,373
Unrestricted designated funds 13,484 13,624
Restricted income funds 844 1,118
24,468 25,115

Income from donations
and		 legacies
2023 2022
Kk Kk
Donations 787 2,015
Legacies 2,098 3,138
2,885 5,153

2023 2022
Kk Kk
Grants and contract income from
Integrated
Care Boards:
Inpatient
and day services		 1,567 1,511
HospiceHome 340 340
1,907 1,851
Other funding:
NHS Pension contributions paid directly by NHS England 114 97
COVID-19 grant paid by NHS England 458
Coronavirus
Job Retention		 Scheme 17
Carer Support Service 63
Pharmacy
Services		 26
Project Echo 42 52
Total income from charitable activities 2,152 2,475

2023 2022
Rk Rk
Income from the sale of donated goods 2,414 2,029
Income from the sale of bought in goods 63 64
Retail grant (through trading subsidiary) 35
Total income from shops 2,477 2,128
Costs of buying in goods (34) (30)
Staff costs (1,059) (977)
Other costs (821) (689)
Total expenditure on shops (1,914) (1,696)
Net profit arising from shops 563 432

The summa ry
financial
performance		 of t he subsidiary
a		 lone is:
2023 2022
Rk Rk
Trading Income 63 64
Retail grant
Cost ofsales and administration costs (39) (34)
Net profit 24 30
Amount gift aided to the charity (24) (30)
Retained in subsidiary
The assets and liabilities of the subsidiary were:
2023 2022
Rk Rk
Current assets 60 69
Current liabilities (27) (36)
Capital Loan (20) (20)
Total net assets 13 13
Aggrega te
share capital and reserves		 13 13
2023 2022
Rk Rk
Income from lottery sales 398 387
Prizes (37) (37)
Other lottery costs (159) (155)
(196) (192)
Total lottery profits 202 195

2023 2022
Kk Kk
Fundraising
events and activities		 223 332
Provision of placements/training 21 10
courses
Room hire 3 3
Catering
for staff and		 visitors 15 10
Industrial
injury claims for treating
patients
with mesothelioma		 29
Generating
electricity		 4
Sponsorship
income		 19
Miscellaneous
income		 8
Total income from fundraising activities 293 394
Cost of fundraising
events and activities		 (158) (151)
Surplus on fundraising events and
activities

e charity received inv estment
income from		 the following so urces du
2023 2022
Rk Rk
Dividends 339 399
Rents from investment properties 6 7
Interest on cash deposits 46 1
391 407

Restricted
Funds		 Movement in Funds
Year ended 31 March 2023 01-Apr 31-Mar
2022 Income Expenditure 2023
Kk Kk Kk
Hospice@Home service 977 374 (666) 685
Personalised
Care		 Project (26) 37
Hospice@Home vehicle 40 (15) 25
Workforce development 3
Project Echo 43 (43)
ACP Funding
Equipment
Funds		 2 (1) 12
Carer Support Service 63 (10) 53
Pharmacy
Services		 26 (26)
Drugs 8,oxygen 80 (80)
Homelessness
Project.		 3 (2) 9
Sundry other funds 6 (5) 10
1,118 600 (874) 844
Restricted
Funds		 Movement in Funds
Year ended 31 March 2022 01-Apr 31-Mar
2021 Income
Expenditure		 2022
Rk
HospiceHome
service		 1,362 (385) 977
Personalised
Care		 Project 63 63
HospiceHome
vehicle		 40 40
Workforce development
Project Echo 52 (52)
ACP Funding
Equipment
Funds
Service extension/ Covid Co-ordinator 72 (72)
NHS England
COVID-19 grant		 475 (475)
Drugs 8,oxygen 78 (78)
Homelessness
Project		 38 (39)
Sundry other funds 5 (4)
110 2,113 (1,105) 1,118

nd overhea d
costs of		 this project, this project, which reached a conclusio n
in 2023		 . .
Year ended 31 March 2023 Movement in Funds
01-Apr 2022 Income Expenditure Designation 31-Mar 2023
Kk Kk Kk Kk Kk
Unrestricted Funds 10,386 7,996 (8,227) 10,155
Designated Funds
Fixed Assets Fund 4,624 (140) 4,484
Building redevelopment fund 7,000 7,000
Retail development fund 1,500 1,500
Digital transformation fund 500 500
24,010 7,996 (8,367) 23,639
rior year ar e restated as below to as below to align with the ne w accounti ng
treatm		 ent: ent:
Year ended 31 March 2022 Movement in Funds
01-Apr 2021 Income Expenditure Designation 31-Mar 2022
Rk Rk Rk Rk Rk
Unrestricted Funds 21,471 9,303 (6,764) (13,624) 10,386
Designated Funds
Fixed Assets Fund 4,624 4,624
Building redevelopment fund 7,000 7,000
Retail development fund 1,500 1,500
Digital transformation fund 500 500
21,471 9,303 (6,764) 24,010

1.
Analysis
o		 1.
Analysis
o		 f expenditu re
including		 governance and supp ort costs
Forthe year ended 31 March Direct Support Governance Total
2023 Costs Costs Costs 2023
Kk Kk Kk Kk
Costs ofraising funds:
Donations and legacies 610 170 1 781
Shops 1,502 409 3 1,914
Lottery 196 196
Fundraising and other activities 124 34 158
Investment management costs 80 80
Expenditure on charitable
activities:
In-patient care 3,361 789 5 4,155
Hospice@Home 946 263 2 1,211
Bereavement
and family		 support 153 42 195
Total expenditure 6,972 1,707 11 8690

Support C osts
HR, Health
fl Safety
and Volunteers		 Finance and
Information		 Systems Administration Total 2023
Kk Kk Kk Kk
Donations and legacies 83 40 47 170
Shops 201 97 111 409
Fundraising activities 17 8 9 34
In-patient care 388 188 213 789
HospiceHome 129 63 71 263
Bereavement
family support		 and 21 10 42
839 406 462 1,707

a comparative, a comparative, the expenditure
for the prior		 the expenditure
for the prior		 ye ar is sho wn below on the same basis:
Forthe year ended 31 March 2022 Direct
Costs		 Support
Costs		 Governance
Costs		 Total 2022
Kk Kk Kk Kk
Costs ofraising funds:
Donations and legacies 476 115 592
Shops 1,370 324 1,696
Lottery 192 192
Fundraising and other activities 121 30 151
Investment management costs 81 81
Expenditure on charitable activities:
In-patient care 3,090 676 3,771
Hospice@Home 912 220 1,134
Bereavement and family support 203 49 252
Total expenditure 6,445 1,414 10 7,869
Support Costs
HR, Health & Finance and
Safety and Information Administration Total 2022
Volunteers Systems
Rk Rk Rk Rk
Donations and legacies 54 30 31 115
Shops 153 85 86 324
Fundraising activities 14 8 8 30
In-patient care 319 177 180 676
Hospice@Home 104 57 59 220
Bereavement and family 23 13 49
support
667 370 377 1,414

This is stat ed affer chargin g:
2023 2022
Rk Rk
Depreciation
of tangible		 fixed assets 186 179
Auditor's remuneration:
Audit fees 13 10
Non audit services 1 13
Operating
equipment		 lease rentals —land and buildings and 195 186
Profit on disposal of fixed assets (7)
2023 2022
Wages and salaries 5,583 5,170
Social security costs 522 465
Pension costs 646 587
6,751 6,222
of employees
who received employ
in bands of f.10,000 is:		 ee
benefits during the year		 in excess o
2023 2022
260,001 - 270,000 4 2
270,001 —280,000 1
280,001 - 290,000
290,001 —2100,000
2110,000 - f120,000

cluding
pa		 rt-time
a		 nd bank s taff) during t he year were as follows:
2023 2022
Head Full Time Head Full Time
Count Equivalent Count Equivalent
Charitable services 134 100 128 97
Income generation, including shops 67 51 64 48
Support services 26 20 24 17
227 171 216 162

Retail Retail Fixtures
Freehold Leasehold Point
sale		 of Fittings Medical Motor
Property Property System Plant Equip Equip Vehicles Totals
Kk Kk Kk Rk Kk Kk Kk Kk
Cost:
At
1 April 2022		 6,601 38 38 82 220 191 164 7,334
Additions 14 9 3 — 30 56
Disposals (20) (20)
At 31 March
2023		 6,601 52 38 91 223 191 174 7,370
Depreciation
At
1 April 2022		 2,230 23 32 159 99 134 2,710
Charge for the 121 8 7 18 14 16 186
year
On Disposals (10) (10)
At 31 March
2023		 2,351 35 31 39 177 113 140 2,886
Net Book
Values
At 31 March
2023		 4,250 17 7 52 46 78 34 4,484
At 31 March
2022		 4,371 15 50 61 92 30 4,624

.
Fixed asset investmen		 ts
The Charity and the Group
Investments 2023 2022
Kk Kk
Market value at
1 April 2022		 14,909 14,516
Additions at cost 2,728 501
Disposal proceeds (500)
17,637 14,517
Realised and unrealised
investment
gains/(losses)		 (551) 472
Investment
management		 costs (78) (80)
Charges
within valuation
Market value at 31 March 2023 17,008 14,909

Invest ment
 Pro perty
2023 2022
Kk Kk
Market value at 1 April 105 105
Market value at 31 March 105 105

vestme nt in subsidiary
The Charity
2023 2022
Shares at cost 100 100

Charity Group
2023 2022 2023 2022
Kk Kk Kk Kk
Goods for resale 16 16 17
.
Debtors
Charity Group
2023 2022 2023 2022
Rk Rk Rk Rk
Trade debtors 34 26 34 27
Amount owed by subsidiary 33 54
Other debtors 69 267 69 267
Prepayments 140 123 140 123
Accrued income 2,300 2,869 2,300 2,869
2,576 3,339 2,543 3,286
Charity
Amounts Owed by Subsidiary 2023 2022
Kk Kk
Due within one year 13 34
Capital Loan 20 20
33 54

.
Creditors: amounts
falling d		 ue within one year
Charity Group
2023 2022 2023 2022
Kk Kk Kk Kk
Trade creditors 160 147 159 146
Taxes and social security costs 194 185 194 185
Other creditors
Accruals 47 52 49 55
Deferred Income 74 48 74 48
475 432 476 434
At 31
2022		 March Released
during year		 D f d At 31
2023		 March
Rk Rk Rk Rk
Deferred Income 48 (48) 74 74

23.
Analysis		 of group net assets between funds
Fund balances
are represented		 at 31 March 2023
by:		 G Unrestricted
eneral
Funds		 Unrestricted
Designated
Funds		 Restricted
Funds		 Total
Kk Kk Kk Kk
Tangible fixed assets 4,484 4,484
Investments 8,113 9,000 17,113
Current assets 2,518 844 3,362
Current
liabilities		 (476) (476)
Total net assets 10,155 13,484 844 24,483
Fund balances
are represented		 at 31 March 2022
by:		 Unrestricted
General
Funds		 Unrestricted
Designated
Funds		 Restricted
Funds		 Total
Rk Rk Rk Rk
Tangible fixed assets 4,624 4,624
Investments 6,014 9,000 15,014
Current assets 4,806 1,118 5,924
Current
liabilities		 (434) (434)
Total net assets 10,386 13,624 1,118 25,128

2023 2022 2023 2022
Land L
Buildings		 Land &
Buildings		 Other Other
Due within one year 140 183
Due between two and five years 190 205
Due after 5years
334 388

2023 2022
Rk Rk
Net movement
in funds		 (94) 3,075
Adjustments
for:
Dividends
interest and rents from		 investments (391) (407)
Depreciation
charges		 186 179
Profit on sale of fixed assets (7)
Investment
management		 charges 78 80
Decrease
in stocks		 1 2
Decrease/(Increase)
in		 debtors 819 (1,415)
Increase
in creditors		 42 43
Net cash provided
by operating		 activities 634 1,557

alysis ofc hange s
in net funds
At 31 At 31
March Cash flow March
2022 2023
Kk Kk Kk
Cash and cash equivalents 2,621 (1,818) 803

Consolidated
Statement
of		 Financial Activities (Including Financial Activities (Including Financial Activities (Including Income and Expenditure Account)
for the year ending
31 March		 2022
Unrestricted Restricted Total Funds
Funds Funds 2022
Ek
Income from:
Donations
and legacies		 3,432 1,721 5,153
Income from charitable activities:
Grants and contract income 2,083 392 2,475
Income from other trading activities:
Shops 2,128 2,128
Lottery 387 387
Fundraising
activities		 394 394
Investment
Income		 407 407
Total income 8,831 2,113 10,944
Expenditure
on:
Costs ofraising funds:
Donations
and legacies		 592 592
Shops 1,696 1,696
Lottery 192 192
Fundraising
activities		 151 151
Investment
Management		 Costs 81 81
Expenditure
on charitable		 activities:
In-patient
Care		 3,051 720 3,771
Sunflower Centre
Hospice@Home 749 385 1,134
Lymphoedema
Service
Bereavement
and Family Support		 252 252
Total expenditure 6,764 1,105 7,869
Net income before other recognised gains 2,067 1,008 3,075
Realised and unrealised gains on investments 472 472
Net income 2,539 1,008 3,547
Total funds brought
forward		 21,471 110 21,581
Total funds carried forward 24,010 1,118 25,128